Altus Capital Partners, Inc.’s $50.3 Million Acquisition of MGC Diagnostics Corporation


Ballard Spahr advised MGC Diagnostics Corporation (MGC) in its $50.3 million sale to private equity firm Altus Capital Partners, Inc.

MGC is a global medical technology company focused on cardiorespiratory health solutions. The company, led by Todd M. Austin and Matthew S. Margolies, is based in Saint Paul. The conclusion of the tender offer and subsequent cash-out merger for all outstanding shares of MGC’s common stock effectively takes the company private and positions MGC for product innovation and growth.

Altus Capital Partners, Inc. operates as a private equity firm. The Company invests in middle market manufacturing companies.

Ballard Spahr advised MGC Diagnostics Corporation with a team including Jonathan Levy (Picture), Thomas Lovett, IV, Jamie Buskirk and Christian Barnes

Involved fees earner: Jonathan Levy – Ballard Spahr Stillman & Friedman LLP; Thomas Lovett – Ballard Spahr Stillman & Friedman LLP; Jamie Buskirk – Ballard Spahr Stillman & Friedman LLP; Christian Barnes – Ballard Spahr Stillman & Friedman LLP;

Law Firms: Ballard Spahr Stillman & Friedman LLP;

Clients: MGC Diagnostics Corporation;

Avatar

Author: Ambrogio Visconti